Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

AI in the life sciences – the good, the bad and the ugly

Posted on November 7th, 2018 by in Pharma R&D

Everyone in the life science industry – from the C-suite in the boardroom to scientists at the bench – are talking about the potential of AI, especially now they’re starting to see pharma companies using the technology. And we are beginning to see researchers mixing diverse kinds of data together – images, text and numeric data to name a few – to learn from. Continue reading “AI in the life sciences – the good, the bad and the ugly” »

How Pharma Can Make the Most of Gene Tech CRISPR

Posted on December 18th, 2017 by in Pharma R&D

puzzle-2500333_960_720

The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. Continue reading “How Pharma Can Make the Most of Gene Tech CRISPR” »